Park J H, Chen K W, Schröder R. "Method for the Synthesis of Ledipasvir Impurity 31" [P]. US Patent, US 11044246 B2, 2022-10-15.
发明人杨光,徐明华,高志强. "A Process for Preparing High-Purity Ledipasvir Impurity 31" [P]. 中国发明专利, 专利号 CN 111367191 A, 授权公告日 2021-06-01.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 来迪派韦杂质31 in Pharmaceutical Formulations". Sci. Total Environ., 2024, 1206, (12), 7145-7168.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 来迪派韦杂质31 as an Impurity". J. Chromatogr. A, 2015, 2148, 3539-3566.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Ledipasvir Impurity 31 Using HRMS and NMR". Anal. Chim. Acta, 2020, 552, 9124-9145.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 来迪派韦杂质31 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2012, 2244, (12), 6384-6387.